GRTS — Gritstone bio Cashflow Statement
0.000.00%
Last trade - 00:00- $89.09m
- $49.96m
- $16.34m
Annual cashflow statement for Gritstone bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -94.4 | -105 | -75.1 | -120 | -138 |
| Depreciation | |||||
| Non-Cash Items | 10.3 | 14.5 | 19.4 | 21.7 | 26.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.66 | -4.93 | -1.36 | -24.5 | -17.1 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -85 | -89.1 | -50.7 | -116 | -122 |
| Capital Expenditures | -16.2 | -3.52 | -5.46 | -5.87 | -4.57 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 32 | 69.5 | -113 | -7.09 | 107 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 15.8 | 65.9 | -119 | -13 | 102 |
| Financing Cash Flow Items | -0.807 | -0.104 | -8.39 | -1.31 | -3.49 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 74.4 | 136 | 109 | 83.1 | 25.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.22 | 113 | -60.5 | -45.8 | 5.81 |